Argenx
ARGX
#474
Rank
NZ$87.26 B
Marketcap
NZ$1,410
Share price
1.82%
Change (1 day)
17.89%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

P/S ratio for Argenx (ARGX)

P/S ratio as of January 2026 (TTM): 13.9

According to Argenx 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 8.23. At the end of 2025 the company had a P/S ratio of 12.5.

P/S ratio history for Argenx from 2022 to 2021

PS ratio at the end of each year

Year P/S ratio Change
202512.5-26.98%
202417.1-7.07%
202318.4-63.94%
202251.0-17.8%
202162.1
201978.6-34.76%
2018120201.52%
201739.9
201425.2